Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
22.59
0.00 (0.00%)
Jul 21, 2026, 9:39 AM EDT - Market open
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $374.33 million as of July 21, 2026. Its market cap has increased by 485.61% in one year.
Market Cap
374.33M
Enterprise Value
185.40M
1-Year Change
485.61%
Ranking
Category
Stock Price
$22.59
ChartMarket Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has increased from $346.92M to $374.33M, an increase of 7.90%. That is a compound annual growth rate of 0.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 390.57M | 296.23% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| vTv Therapeutics | 408.02M |
| C4 Therapeutics | 407.99M |
| Century Therapeutics | 405.80M |
| Enanta Pharmaceuticals | 399.54M |
| Abeona Therapeutics | 398.97M |
| DiaMedica Therapeutics | 393.35M |
| Atea Pharmaceuticals | 389.73M |
| Larimar Therapeutics | 386.22M |